Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Evaluation, management and treatment of sunburn in adults.

BIBLIOGRAPHIC SOURCE(S)

  • University of Texas, School of Nursing, Family Nurse Practitioner Program. Evaluation, management and treatment of sunburn in adults. Austin (TX): University of Texas, School of Nursing; 2007. 24 p. [20 references]

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Strength of recommendations (A, B, C, D, I) and quality of evidence (good, fair, poor) are defined at the end of "Major Recommendations" field.

Practice Recommendations - Part A: Evaluation and Treatment

Recommendation 1

Methods to Reduce Inflammation

  • Cooling, ice packs (Han, 2004)
  • Nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen (Morgan, 2000)
  • Topical corticosteroids (Duteil et al., 2002; Han, 2004)
  • Systemic corticosteroids (not recommended) (Han, 2004)

(Grade of recommendation = A; Quality of Evidence = Good)

Recommendation 2

Methods to Prevent Infection in Sunburn

  • Diligent wound care with mild soap and water (Hudspith & Rayatt, 2004; Morgan, 2000)
  • Application of non-adherent dressings if open areas present (Dowsett, 2002)
  • Sterile saline soaks (Dowsett, 2002)
  • Care of blisters, blebs (keep intact if possible and cover open wounds with sterile dressings) (Dowsett, 2002; Morgan 2000)
  • Tetanus prophylaxis for burns deeper than superficial partial thickness (Kagan, 2002; Morgan, 2000)
  • Topical antibiotics such as Bacitracin, or Silvadene (Kagan, 2002; Morgan, 2000)
  • Simple dressings such as Telfa, Duoderm, Granuflex, Mepitel (Hudspith & Rayatt, 2004)
  • Oral or injectable antibiotics (not recommended) (Dowsett, 2002)
  • Chlorhexidine, povidone iodine (not recommended) (Morgan, 2000)
  • Biologic dressings such as Burnsheild or Rescue Derm (Hudspith & Rayatt, 2004; Martineau & Dosch, 2006)

(Grade of Recommendation = B; Quality of Evidence= Good)

Recommendation 3

Comprehensive Pain Assessment

Methods to Evaluate Pain

  • Location of pain
  • Effect of pain on function and activities of daily living (i.e., work, interference with usual activities, etc.)
  • Level of pain at rest and during activity
  • Medication usage
  • P - provoking or precipitating factors
  • Q - quality of pain (what words does the person use to describe pain? - aching, throbbing)
  • R - radiation of pain (does the pain extend from the site?)
  • S - severity of pain (intensity, 0-10 scale)
  • T - timing (occasional, intermittent, constant)

(Grade of Recommendation = C; Quality of Evidence= Good)

A standardized tool with established validity is used to assess the intensity of pain.

  • Visual Analogue Scale (VAS)
  • Numeric Rating Scale (NRS)
  • Verbal Scale
  • Faces Scale
  • Behavioral Scale

(Grade of Recommendation = C; Quality of Evidence= Good)

Pharmacological Management of Pain: Selecting Appropriate Analgesics

Using the WHO (World Health Organization) Stepwise Approach to Pain

Ensure that the selection of analgesics is individualized to the person, taking into account:

  • The type of pain (acute or chronic, nociceptive and/or neuropathic)
  • Intensity of pain
  • Potential for analgesic toxicity (age, renal impairment, peptic ulcer disease, thrombocytopenia)
  • General condition of the person
  • Concurrent medical conditions
  • Response to prior or present medications
  • Cost to the person and family
  • The setting of care

(Grade of Recommendation = A; Quality of Evidence = Good)

Recognize that acetaminophen or non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are used for the treatment of mild pain and for specific types of pain as adjuvant analgesics unless contraindicated.

(Grade of Recommendation = A; Quality of Evidence = Good)

Recognize that opioids are used for the treatment of moderate to severe pain, unless contraindicated, taking into consideration:

  • Previous dose of analgesics
  • Prior opioid history
  • Frequency of administration
  • Route of administration
  • Incidence and severity of side effects
  • Potential for age related adverse effects
  • Renal function

(Grade of Recommendation = A; Quality of Evidence = Good)

Consider the following pharmacological principles in the use of opioids for the treatment of severe pain:

  • Mixed agonist-antagonists (e.g., pentazocine) are not administered with opioids because the combination may precipitate a withdrawal syndrome and increase pain.
  • The elderly generally receive greater peak and longer duration of action from analgesics than younger individuals, thus dosing should be initiated at lower doses and increased more slowly ("careful titration").

(Grade of Recommendation = B; Quality of Evidence = Good)

Recommendation 4

Methods to Treat Pain/Discomfort

  • Non-steroidal anti-inflammatory drugs, acetaminophen (Morgan, 2000)
  • Aspirin (Morgan, 2000)
  • Topical anesthetics, analgesics such as Propolis, Solarcaine, or Witch Hazel (Ackerson, 2004; "Sunburn," 2006; Gregory et al., 2002)
  • Short course of codeine or oxycodone (Hudspith & Rayatt, 2004; Oldfield & Perry, 2006; Brown, 2004)
  • Anti-pruritics; Benadryl, Periactin, Atarax (Han, 2004)
  • Bicarbonate of soda baths, Calamine lotion (Morgan, 2000)
  • Green tea, cucumber, Echinaea, Mimosa tenuiflora (Duke, 2002; Schar & Altshul, 2003)
  • General comfort measures; emollients, cool compresses, oatmeal soaks (Ackerson, 2004; "Sunburn," 2006; Perez, 2006)
  • Relaxation and imagery (Kagen, 2002)
  • Petroleum jelly, benzocaine, lidocaine, butter or greasy ointments (not recommended) (Perez, 2006)

(Grade of Recommendations = B; Quality of Evidence = Good)

Recommendation 5

Methods to Promote Healing

  • Healthy diet with adequate protein (Johns Hopkins, 2006)
  • Adequate hydration (Kagen, 2002)
  • Rest (Johns Hopkins, 2006)
  • Avoidance of alcohol (Johns Hopkins, 2006)
  • Use of non-perfumed moisturizing lotions once epithelialization occurs to promote natural lubricating mechanisms (Perez, 2006)
  • Avoidance of direct intense sun exposure (Perez, 2006)
  • Loose comfortable clothing (Johns Hopkins, 2006)

(Grade of Recommendation = C; Quality of Evidence = Fair)

Recommendation 6

Alternative Therapies

  • Vitamin C, E (Kagen, 2002)
  • Aloe Vera (Ackerson, 2004)
  • Oatmeal baths (Ackerson, 2004, Perez, 2006)
  • Antioxidants (not recommended) (Han, 2004)
  • Topical melatonin (not recommended) (Han, 2004)
  • Milk ("Post-sunburn soothers," 2005)

(Grade of Recommendation = C; Quality of Evidence = Fair)

Practice Recommendations- Part B- Management

Follow-up

  • Follow-up one day after initial visit
  • Weekly until wound epithelialization begins
  • Concurrent evaluation for infection/complications

Patient Teaching

  • General care to promote healing and prevent infection
  • Signs and symptoms of infection/complications
  • Medication/wound care
  • When to follow-up
  • Sunburn protection

(Grade of Recommendation = C; Quality of Evidence = Good)

Definitions:

Quality of Evidence (Based on U.S. Preventative Services Task Force Ratings)

  • Good: Evidence includes consistent results from well-designed, well-conducted studies in representative populations that directly assess effects on health outcomes.
  • Fair: Evidence is sufficient to determine effects on health outcomes, but the strength of the evidence is limited by the number, quality, or consistency of the individual studies, generalizability to routine practice, or indirect nature of the evidence on health outcomes.
  • Poor: Evidence is insufficient to assess the effects on health outcomes because of limited number or power of studies, important flaws in their design or conduct, gaps in the chain of evidence, or lack of information on important health outcomes.

Strength of Recommendations (Based on the U.S. Preventive Services Task Force Ratings)

A. There is good evidence that the recommendation improves important health outcomes. Benefits substantially outweigh harms.

B. There is at least fair evidence that the recommendation improves important health outcomes. Benefits outweigh harms.

C. There is at least fair evidence that the recommendations can improve health outcomes but the balance of benefits and harms is too close to justify a general recommendation.

D There is at least fair evidence that the recommendation is ineffective or that harms outweigh benefits.

I. Evidence that the recommendation is effective is lacking, of poor quality, or conflicting, and the balance of benefits and harms can not be determined.

CLINICAL ALGORITHM(S)

An algorithm is provided in the original guideline document for "Depth assessed (appearance, bleeding, blistering, capillary refill, sensation)."

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

These recommendations were based primarily on sources such as national guidelines, meta-analysis review, and evidenced-based, randomized, controlled research studies. Guidelines and statements are synthesized to make them applicable to the treatment of sunburn.

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • University of Texas, School of Nursing, Family Nurse Practitioner Program. Evaluation, management and treatment of sunburn in adults. Austin (TX): University of Texas, School of Nursing; 2007. 24 p. [20 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2007

GUIDELINE DEVELOPER(S)

University of Texas at Austin School of Nursing, Family Nurse Practitioner Program - Academic Institution

SOURCE(S) OF FUNDING

University of Texas at Austin, School of Nursing, Family Nurse Practitioner Program

GUIDELINE COMMITTEE

Practice Guidelines Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Guideline Development Panel Members: Vicki Greene, RN, MSN, FNP; Patricia Roberts, RN, MSN, FNP; Beth Weidner, RN, MSN, FNP

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: None available

Print copies: Available from the University of Texas at Austin, School of Nursing. 1700 Red River, Austin, Texas, 78701-1499

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on August 23, 2007. The information was verified by the guideline developer on November 9, 2007.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which may be subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo